A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer.
| Author | |
|---|---|
| Abstract |
:
Nanoparticle albumin-bound (nab)-paclitaxel was developed to improve paclitaxel solubility and does not need premedication to avoid infusion-related reactions associated with solvent-based (sb)-paclitaxel. We conducted a phase II trial to investigate the efficacy and safety of nab-paclitaxel plus ramucirumab combination therapy for previously treated advanced gastric cancer. |
| Year of Publication |
:
2018
|
| Journal |
:
European journal of cancer (Oxford, England : 1990)
|
| Volume |
:
91
|
| Number of Pages |
:
86-91
|
| Date Published |
:
2018
|
| ISSN Number |
:
0959-8049
|
| URL |
:
http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(17)31513-7
|
| DOI |
:
10.1016/j.ejca.2017.11.032
|
| Short Title |
:
Eur J Cancer
|
| Download citation |
